Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long-term safety (TATE study).
Wedner HJ, Fujisawa T, Guilbert TW, Ikeda M, Mehta V, Tam JS, Lukka PB, Asimus S, Durżyński T, Johnston J, White WI, Shah M, Werkström V, Jison ML; all TATE investigators.
Wedner HJ, et al. Among authors: tam js.
Pediatr Allergy Immunol. 2024 Mar;35(3):e14092. doi: 10.1111/pai.14092.
Pediatr Allergy Immunol. 2024.
PMID: 38491795